![Drew Young](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Drew Young
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Drew Young
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
FerGene, Inc.
![]() FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ontario Institute for Cancer Research
![]() Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | President | |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
SYNTHORX, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Santa Clara University | College/University | Undergraduate Degree | |
ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The University of Texas at Austin | College/University | Doctorate Degree | |
University of Toronto | College/University | Doctorate Degree | |
Israel Biotech Fund
![]() Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor | |
Fight Against Cancer Innovation Trust
![]() Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member | |
Sharsheret, Inc.
![]() Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Sharsheret, Inc. is a leading Jewish cancer organization that provides free support and educational programs for breast cancer survivors. The non-profit company is based in Teaneck, NJ and the CEO of the company is Elana Silber. The company's program, Best Face Forward 2.0, offers services and subsidies for eligible individuals for non-medical services critical to a woman's quality of life. The company also offers support and resources for those who are BRCA+ or have a family history of BRCA. | Miscellaneous Commercial Services | Director/Board Member | |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Columbia University Vagelos College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
CELGENE | Biotechnology | Corporate Officer/Principal | |
Harvard Medical School | College/University | Doctorate Degree | |
Barnard College | College/University | Undergraduate Degree | |
Tectonic Therapeutic, Inc.
![]() Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tectonic Therapeutic, Inc., Tectonic Operating Co., Inc. is a company that is transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company is based in Watertown, MA. With its proprietary Geode™ platform, Tectonic aims to unlock the therapeutic utility of some of the most difficult receptors in the class. The company was founded by Andrew Kruse and Timothy A. Springer. Alise S. Reicin has been the CEO of the company since 2020. Tectonic Operating Co. was acquired by AVROBIO, Inc. on June 20, 2024 for $7.56 million. | Miscellaneous Commercial Services | Chief Executive Officer | |
IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
OncoResponse, Inc.
![]() OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Rush Medical College | College/University | Doctorate Degree | |
CG ONCOLOGY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sanofi, Inc. (China)
![]() Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The company is based in Shanghai, China. | Pharmaceuticals: Major | Private Equity Investor | |
Washington University School of Medicine | College/University | Graduate Degree | |
Jilin University | College/University | Undergraduate Degree | |
Yonjin Venture LLC
![]() Yonjin Venture LLC Investment ManagersFinance Yonjin Venture LLC (Yonjin Venture) is a venture capital subsidiary of Yongjin Group, Inc. founded in 2018. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Ultivue, Inc.
![]() Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Metabomed Ltd.
![]() Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Qualigen, Inc.
![]() Qualigen, Inc. Medical SpecialtiesHealth Technology Qualigen, Inc. operates as a biotechnology company that develops and commercializes novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a diagnostic platform. The company was founded by Michael S. Poirier in 1996 and is headquartered in Carlsbad, CA. | Medical Specialties | President | |
MIRATI THERAPEUTICS | Biotechnology | Chief Tech/Sci/R&D Officer | |
Fairleigh Dickinson University | College/University | Undergraduate Degree | |
QUALIGEN THERAPEUTICS, INC. | Pharmaceuticals: Other | President | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Sales & Marketing | |
VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Yale Cancer Center
![]() Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Corporate Officer/Principal | |
Yale University | College/University | Corporate Officer/Principal | |
University of Vermont | College/University | Doctorate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
CURIS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ImmunOs Therapeutics AG
![]() ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith. | Biotechnology | Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistik
International
Vereinigte Staaten | 41 |
Kanada | 4 |
Israel | 3 |
China | 3 |
Deutschland | 2 |
Sektoral
Health Technology | 28 |
Consumer Services | 15 |
Finance | 4 |
Health Services | 3 |
Commercial Services | 3 |
Operativ
Corporate Officer/Principal | 36 |
Director/Board Member | 26 |
Chief Tech/Sci/R&D Officer | 15 |
Undergraduate Degree | 11 |
Independent Dir/Board Member | 9 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Paris Panayiotopoulos | 18 |
Allene Diaz | 14 |
Alise Reicin | 13 |
Joseph Leveque | 12 |
Bharat Tewarie | 9 |
Alex Kuta | 8 |
Daguang Wang | 8 |
David Tuck | 7 |
Laszlo Radvanyi | 6 |
Amy Broidrick | 6 |
Vijay Kasturi | 6 |
Matthew Schiller | 5 |
Frederick E. Munschauer | 5 |
Chris Mancill | 1 |
- Börse
- Insiders
- Drew Young
- Unternehmensverbindungen